In ₹ Crore except Per Share Latest Annual	SPARC FY26	STAR FY26	SHILPAMED FY26	SUPRIYA FY25	Peer Average
Valuation — at last close
P/E	◆ 3.60×	16.59×	70.41×	—	43.50× -92%
P/B	4.18×	◆ 2.97×	6.61×	—	4.79× -13%
EV/EBITDA	◆ 3.85×	11.59×	40.82×	—	26.21× -85%
Market Cap	₹5,598 Cr	₹9,227 Cr	₹17,133 Cr	—	₹13,180 Cr -58%
Growth
Revenue CAGR 3Y	◆ 95.98%	9.62%	13.59%	—	11.61% +727%
Revenue CAGR 5Y	—	7.94%	◆ 11.30%	—	9.62%
Revenue YoY (latest Q)	◆ 314.11%	17.11%	44.90%	—	31.00% +913%
Net Income YoY (latest Q)	59.94%	1.97%	◆ 115.16%	—	58.56% +2%
Profitability
EBITDA Margin	◆ 85.08%	19.04%	28.25%	—	23.64% +260%
Net Income Margin	◆ 82.65%	11.82%	15.81%	—	13.82% +498%
Return on Common Equity	◆ 277.35%	19.66%	9.80%	—	14.73% +1783%
Return on Capital Employed	◆ 230.55%	19.31%	11.47%	—	15.39% +1398%
Return on Assets	◆ 123.94%	8.86%	6.94%	—	7.90% +1469%
Credit & Quality
Total Debt/Equity	0.42×	0.53×	0.25×	◆ 0.00×	0.26× +62%
Interest Coverage	◆ 46.54×	4.05×	5.36×	—	4.71× +889%
Scale — latest FY
Revenue / Total Income	₹1,879 Cr	₹4,859 Cr	₹1,539 Cr	—	₹3,199 Cr -41%
Net Income	₹1,553 Cr	₹575 Cr	₹243 Cr	—	₹409 Cr +280%
Total Assets	₹2,171 Cr	₹6,927 Cr	₹3,706 Cr	₹1,112 Cr	₹3,915 Cr -45%
EPS	₹47.86	₹60.34	₹12.44	—	₹36.39 +32%
Book Value per Share	₹41.26	₹337.14	₹132.47	—	₹234.81 -82%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.